Medicine
Jivi kit
Jivi kit is a prescription medicine containing Antihemophilic factor pegylated, marketed by Bayer HealthCare, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Do not freeze. Once stored at room temperature, do not return the product to…
Key facts
- Active ingredient (INN)
- Antihemophilic factor pegylated
- Brand
- Jivi
- Dosage form
- Kit
- Packs
- 1 kit and 7 more
- Marketing authorisation holder
- Bayer HealthCare
- Manufacturer
- Bayer HealthCare
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Once stored at room temperature, do not return the product to the refrigerator. Store JIVI at +2°C to +8°C (36°F to 46°F) for up to 24 months from the date of manufacture. Within this period, JIVI may be stored for a single period of up to 6 months at temperatures up to +25°C or 77°F. Record the starting date of room temperature storage on the unopened product carton.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3002.12Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 August 2018
- Identifiers
- RxCUI 2055659, 2055664DailyMed set ID f04e5bd5-d7e2-453b-a407-2616d81a695dNDC 0026-3946, 0026-3944, 0026-3948 +2Application BLA125661
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 box * 2.5 mL in 1 vial * 2.5 mL in 1 syringe * 2.5 mL in 1 vial, single-use | 0026-3942-25 | Bayer HealthCare | 30 August 2018 |
| 1 kit in 1 box * 2.5 mL in 1 vial * 2.5 mL in 1 syringe * 2.5 mL in 1 vial, single-use | 0026-3942-99 | Bayer HealthCare | 30 August 2018 |
| 1 kit in 1 box * 2.5 mL in 1 vial * 2.5 mL in 1 syringe * 2.5 mL in 1 vial, single-use | 0026-3944-25 | Bayer HealthCare | 30 August 2018 |
| 1 kit in 1 box * 2.5 mL in 1 vial * 2.5 mL in 1 syringe * 2.5 mL in 1 vial, single-use | 0026-3944-99 | Bayer HealthCare | 30 August 2018 |
| 1 kit in 1 box * 2.5 mL in 1 vial * 2.5 mL in 1 syringe * 2.5 mL in 1 vial, single-use | 0026-3946-25 | Bayer HealthCare | 30 August 2018 |
| 1 kit in 1 box * 2.5 mL in 1 vial * 2.5 mL in 1 syringe * 2.5 mL in 1 vial, single-use | 0026-3946-99 | Bayer HealthCare | 30 August 2018 |
| 1 kit in 1 box * 2.5 mL in 1 vial * 2.5 mL in 1 syringe * 2.5 mL in 1 vial, single-use | 0026-3948-25 | Bayer HealthCare | 30 August 2018 |
| 1 kit in 1 box * 2.5 mL in 1 vial * 2.5 mL in 1 syringe * 2.5 mL in 1 vial, single-use | 0026-3948-99 | Bayer HealthCare | 30 August 2018 |
| 1 kit in 1 box * 5 mL in 1 vial * 5 mL in 1 syringe * 5 mL in 1 vial, single-use * 5 mL in 1 syringe | 0026-3950-50 | Bayer HealthCare | 2 December 2024 |
| 1 kit in 1 box * 5 mL in 1 vial * 5 mL in 1 syringe * 5 mL in 1 vial, single-use * 5 mL in 1 syringe | 0026-3950-99 | Bayer HealthCare | 2 December 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Antihemophilic factor pegylated kit.
Clinical summary
Antihemophilic factor pegylated is a prescription medicine indicated in adult and pediatric patients with hemophilia A (congenital factor VIII deficiency) for on-demand treatment and control of bleeding episodes, among other approved uses. MedsAcross supplies Antihemophilic factor pegylated for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Antihemophilic factor pegylatedFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ADYNOVATE prescribing information (Takeda Pharmaceuticals Amercia) · U.S. National Library of Medicine, DailyMed
Need Jivi kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.